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Eradication of Transfusion-Induced Malaria by In vitro Processing 




OBJECTIVE: To determine the lethal dose of chloroquine to be added to donors’ blood in vitro for 
eradication of transfusion-induced malaria and to study the unfavorable effects of this dose on the 
constituents of the stored blood. 
METHODS: A total of 4484 blood donors, recruited for this study, were screened for malaria 
parasites microscopically using Giemsa’ staining technique. Only 30 blood samples (200ml of 
blood each) satisfied the inclusion criteria of the study. Each of these blood samples was subdivided 
equally into four sub-samples to obtain 120 sub-samples. Three different concentrations of 
chloroquine were added to 90 specimens (30 samples represent each dose) while 30 specimens 
(control) were left without the drug. Blood specimens were then tested by parasitic, hematological 
and biochemical techniques on the day of collection and after 24 and 48 hours storage in blood 
bank refrigerator. 
RESULTS: The numbers of malaria parasites killed were proportional to chloroquine doses added to 
donors’ blood. No parasites were killed among the control donors’ blood samples. The determined 
lethal dose of chloroquine was safe to all constituents of the stored blood.    
 CONCLUSION: For eradication of transfusion induced malaria by in vitro processing of donors 
blood, chloroquine is effective and safe drug. We recommend application of the optimal dose of 
chloroquine (626.1µg/L) to the components of the blood bags prior to phlebotomy. 
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ransfusion-induced malaria can be a 
fatal complication of an otherwise 
simple medical or surgical 
intervention. It has not been uncommon to 
find that one infected donor has transmitted 
malaria to four or more recipients of his 
blood1.  
Absence of symptoms even for a long period 
does not ensure lack of infectivity2.  
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 All known species of malaria are able to 
survive for days and even weeks in blood 
stored at 4ºC3.  
Malignant tertian malaria (P. falciparum) has 
been transmitted by blood stored for 14 days4 
while benign quartan malaria (P. malariae) 
has been accidentally transmitted in blood 
previously stored for 5 days3, 5.  
Consequently large numbers of parasites can 
be transmitted through this route where as, 
most patients in need of blood transfusion are 
already weakened by severe disease. Malaria 
thus behaves very aggressively in such 
patients6. 
In Sudan, the infection rate of the malaria 
parasite among blood donors was 6.5% using 
direct microscopy (61.9% sensitivity) and 
21% using the PCR. This infectivity is 
T
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considerable and can lead to a higher risk of 
complications and fatality in recipients7. 
This risk is worsened by the practical 
difficulties of the elimination of parasites 
from donors’ blood in vivo, before donation1.  
Also, systemic screening of suspected donors 
is not a practical solution to the problem in 
malarial endemic countries1. Even by using 
an advanced technique several thousand 
parasites might be present in one pint of blood 
and still pass undetected8. 
Moreover, it is neither ethical nor desirable to 
transfuse infected blood to weak, ill patients, 
as the induced disease may be difficult to 
control. A lot of these patients may be 
receiving many different drugs before 
transfusion, which may antagonize 
antimalarial drugs.  These facts denote the 
need for alternative methodologies for the 
selection of blood to be used in transfusion 
that could offer fast, cheap and safe results. It 
is easy, cheap, safe and practical to process 
donors’ blood in vitro with low 
concentrations of chloroquine.  
The concentrations given to a patient from a 
single bag of transfused blood are far low 
compared to the single dose that might be 
offered to donors or transfused patients.  
Thus, it is essential to determine the dose of 
chloroquine, lethal to the malarial parasites, to 
be added to donors’ fresh blood and to detect 
the hematological and biological changes that 
may occur by adding chloroquine to blood 
infected with malarial parasites and is stored 
at 4º – 6º C.  
 
Materials and Methods 
 
This study was conducted in Ahmed Gasim 
Hospital, Khartoum State, Sudan. Using a 
5ml-chloroquine injection which contains 
200mg chloroquine base, three serial 
concentrations of chloroquine phosphate were 
prepared as follows: 0.5ml (20mg), 1ml 
(40mg) and 2ml (80mg) of the injection 
solution were diluted with normal saline to 
obtain 80ml of each dilution with 250, 500 
and 1000 mg/l concentrations consecutively. 
Next, fifty microliters of each were dispensed 
into separate 50ml-blood bags to obtain 250, 
500 and 1000µg/l concentrations subsequent 
to the addition of 50 ml of donors’ blood.   
Sample collection took place between 
October 2002 and January 2004. All 
individuals who donated blood in Khartoum 
state hospitals during the study period were 
included in the study population if they 
satisfied the following criteria:  
1. Presence of malaria parasite in donors’ 
blood films.  
2. Density of infection must range between 
1000 and 80000 parasites/µl (only asexual 
stages were considered). 
3. The parasites grow when cultured in the 
first day. 
4. Donors did not receive quinine within the 
last 7 days, chloroquine within the last 28 
days and Fansidar within the last 14 days. 
One (200ml) pint (CPDA-1) of donors’ 
malaria parasite infected blood was collected 
and subdivided equally into four prepared 
small bags (50ml) using a blood bank mixer 
(Biomixer-323). Three bags were preloaded 
with the three concentrations in addition to 
one bag (control) left without drug.  All blood 
specimens were tested for parasite culture, 
platelets count, total leukocyte count, packed 
red cell volume, lysis percentage, osmotic 
fragility, prothrombin time, activated partial 
thromboplastin time, sodium and potassium 
serum levels simultaneously on the day of 
collection. Thereafter, the bags were stored in 
the blood bank refrigerator (4º-6ºC) and tested 
after 24 and 48 hours using the same 
laboratory procedures.  
The microscopic malarial parasite 
identification technique was performed as 
described by Cheesbrough M.9. The absolute 
number of parasites (number / µL) was 
estimated in the thick blood films by counting 
the parasites against 200 white blood cells, 
multiplied by the total leukocyte count and 
divided by 200.  
In vitro cultivation of erythrocytic stages of 
Plasmodium falciparum was intended for the 
assessment of the sensitivity of fansidar and 
to confirm the viability or death of the 
parasites. It was conducted using RPMI-1640 
medium (GIBCOTM), Invitrogen Corporation. 
The minimum inhibitory concentration (MIC) 
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was determined by computerized probit/log 
dose response analysis, SPSS. Indication of 
resistance was determined by formation of 
schizonts at 8 pmol chloroquine per well or 
more.    
For counting platelets and white blood cells, 
blood samples were diluted 1 in 20 using 
(1%) ammonium oxalate and 1 in 20 using 
(2%) glacial acetic acid solutions 
respectively. They were counted manually by 
haemocytometry using the improved 
Neubauer chamber as described by 
Cheesbrough M.9. 
Partial thromboplastin time is a screening test 
for the intrinsic clotting system, i.e. factors 
XII, XI, IX, VIII, X, V, prothrombin and 
fibrinogen. Prothrombin time is a screening 
test for the extrinsic clotting system, i.e. 
factor VII, X, V, prothrombin and fibrinogen. 
These tests were performed as described by 
Dacie & Lewis10 using the reagent of DiaMed 
company.  
The osmotic fragility test gives an indication 
of the surface area/volume ratio of 
erythrocytes. It measures the effect of the 
applied doses on erythrocytes’ membrane. It 
was performed as described by Dacie & 
Lewis10. 
Packed red cell volume is the proportion of 
whole blood occupied by red cells which was 
measured as described by Dacie & Lewis10. 
Percentage of lysis is a real indicator for 
survival of red blood cells during the storage 
period. Five mls of each blood sample, just 
after collection, was centrifuged for 5 minutes 
at 12000g. The supernatant was stored sterile 
at 4° C to be used as blank. Five hundred 
microliters of the precipitated red cells was 
diluted in 5 mls of pure distilled water and 
stored at 4° C to be used as standard. Both 
solutions were used in the determination of 
percent lysis for the same sample throughout 
the storage period. After 24 and 48 hours one 
milliliter of each blood sample was also 
centrifuged for 5 minutes at 12000g and the 
supernatant of each was read at 540 nm 
wavelength. Lysis percentage was calculated 
by dividing the optical density of the tested 
supernatant by the optical density of the 
standard and multiplied by 100.     
Serum potassium and serum sodium were 
measured by the flame photometry using 
Sherwood Scientific-410 flame photometer. 
Data were analyzed by computer using SPSS 
program. Non-parametric tests were mainly 




 The total number of individuals who donated 
blood was 4956; however, 472 (9.5%) of 
them were rejected on the following bases: 
303 (6.1%) were found to be hepatitis B virus 
carriers while 169 (3.4%) were found to be 
HIV positive.  The collected blood bags 
totaled 4484. All were subjected to screening 
for malaria parasites microscopically using a 
standard Giemsa’ staining technique. A total 
number of 278 (6.2 %) blood bags’ specimens 
were found to carry malaria parasites. The 
parasite densities were less than a thousand in 
215 (77.3%) while parasite-densities of 
greater than a thousand were observed in 63 
(22.7%) specimens. Of these, 30 (10.8%) 
samples were found to be resistant to 
chloroquine. In addition, another three 
(9.09%) samples showed no growth when 
cultured on the first day. Thus, the actual 
number of blood samples for this study was 
reduced according to the above-mentioned 
parameters to only 30.  All of the accepted 
blood bags belonged to asymptomatic male 
donors between 25 and 35 years old.     
 
Table (1) demonstrates the reduction of 
numbers of malaria parasites when different 
concentrations of chloroquine were applied to 
donors’ blood stored for forty-eight hours. 
The control of donors’ blood samples 
(without addition of antimalarials) reveals a 
stable number of parasites even after 48 hours 
storage. 
Parasite counts decreased with the increasing 
concentration of chloroquine and elongation 
of storage period. Thus the parasites 
disappear after 48 hours in samples with the 
higher concentration (1000µg/l) of 
chloroquine. 
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Positivity and mean of the parasite counts during 48-hour storage at 2-8° C  
  






Positivity Mean Positivity Mean Positivity Mean 
C1 30 (100%) 3273 8 (26.7%) 358.67 3 (10%) 47.3 
C2 30 (100%) 3273 5 (16.7%) 263.36 3 (10%) 40.00 
C3 30 (100%) 3273 4 (13.3%) 65.37 0(0%) 00 
Ctrl 30 (100%) 3273 30 (100%) 3273 30(100%) 3273 
 
Key:     C1= 250 µg/l chloroquine      C2= 500 µg/l chloroquine     C3= 1000 µg/l chloroquine   





Doses of chloroquine that kill 50%, 95% and 99% of the parasites (respectively) after 24-hour and 
48-hour storage in a blood bank refrigerator (2-8 °C) 
 
 
Storage period Lethal Doses 
  50% Lethal  95% Lethal  99% Lethal 
Twenty-four hours 183.3 µg/l 496.38 µg/l  626.10 µg/l 
Forty-eight hours 144.2 µg/l 278.48 µg/l 334.14 µg/l 
 
 
Table (2) illustrates the lethal doses of chloroquine.  It was observed that higher doses were 
required when the blood was stored for 24 hours versus 48 hours.  
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Prothrombin time and partial thromboplastin time of the stored blood samples  
 
Sample The first day 24 Hrs Incubation 48 Hrs Incubation 
PT APTT PT APTT PT APTT 
C1 15.67 36.20 16.03 37.60 17.60 39.13 
C2 15.67 36.20 16.40 38.20 18.3 40.13 
C3 15.67 36.20 17.60 39.40 18.97 42.00 
Ctrl 15.67 36.20 15.93 38.400 17.97 40.86 
 
Key:     C1= 250 µg/l chloroquine      C2= 500 µg/l chloroquine     C3= 1000 µg/l chloroquine   
Ctro= control     
 
Table 3 shows the increase in the mean and standard deviation of prothrombin time and partial 
thromboplastin time with the increase of chloroquine dose and storage duration. Minimum increase 
was observed when the minimum concentration of the drug was added.   
Although there is significant statistical difference between the result times among different blood 




Osmotic fragility values of blood samples during the storage period  
 
Sample The first day 24 Hrs Storage 48 Hrs Storage 
Mean SD Mean SD Mean SD 
C1 0.4510 0.00305 0.4550 0.0153 0.460 0.03051 
C2 0.4510 0.00305 0.4650 0.023 0.460 0.02034 
C3 0.4510 0.00305 0.4550 0.0153 0.485 0.04577 
Ctrl 0.4510 0.00305 0.4600 0.031 0.460 0.03050 
 
Key:     C1= 250 µg/l chloroquine      C2= 500 µg/l chloroquine     C3= 1000 µg/l chloroquine   
Ctro= control     
 
Table 4 demonstrates the mean and standard deviation of the osmotic fragilities. It was increased in 
samples with high doses of chloroquine and with increased storage time. No significant statistical 
difference was observed between the results of the control and the different blood samples when 
stored for 24 hours.  
When blood samples stored for 48 hours, correlation between processed blood samples and the 
control reveals statistical similarity, still the upper levels are within the normal.    
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Haematocrit values of blood samples after 24-hour & 48-hour storage at 2-8° C 
 
Sample The first day 24 Hrs Storage 48 Hrs Storage 
Mean SD Mean SD Mean SD 
C1 42.70 2.731 39.20 3.633 37.50 4.125 
C2 42.70 2.731 41.07 11.635 39.20 3.428 
C3 42.70 2.731 40.40 10.071 37.90 5.013 
Ctrl 42.70 2.731 40.50 3.972 39.50 7.960 
 
Key:     C1= 250 µg/l chloroquine      C2= 500 µg/l chloroquine     C3= 1000 µg/l chloroquine   
Ctro= control     
 
Table 5 shows that the packed red cell volume was decreased when the time of storage was 
prolonged regardless of the increase of the doses.   
No significant statistical difference was observed between the results of the control and blood 









The first day 24 Hrs Storage 48 Hrs Storage 
WBC PLTs WBC PLTs WBC PLTs 
C1 3250 225000 2380 196000 2520 193000 
C2 3250 225000 3000 179800 2620 179000 
C3 3250 225000 3520 172600 2470 172000 
Ctrl 3250 225000 2940 208000 3230 178000 
 
Key:     C1= 250 µg/l chloroquine      C2= 500 µg/l chloroquine     C3= 1000 µg/l chloroquine   
Ctro= control. WBC: White blood cell count. PLTs: Platelet count 
 
Table 6 illustrates the mean and standards deviation of the leukocyte and platelet counts. Each 
parameter was decreased when the storage time was prolonged and did not correlate with the dose 
concentration.   
No significant statistical difference was observed between the results of the control and all of the 
processed blood samples when they were stored for 24 or 48 hours.  
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The lysis percentage of the stored red blood cells during storage at 2-8°C 
 
Sample The first day 24 Hrs Storage 48 Hrs Storage 
Mean SD Mean SD Mean SD 
C1 0.000 0.000 0.10 0.06 0.1367 0.08 
C2 0.000 0.000 0.09 0.08 0.54 0.07 
C3 0.000 0.000 0.11 0.08 0.7 0.09 
Ctrl 0.000 0.000 0.09 0.07 0.16 0.1 
 
Key: C1= 250 µg/l chloroquine C2= 500 µg/l chloroquine C3= 1000 µg/l chloroquine Ctro= control     
 
Table 7 shows the lysis percentage had increased when the dose of the drug was high as well as 
when the time of storage was prolonged.   
No significant statistical difference was observed between the result of the control and blood 
samples processed with chloroquine.  
Lysis occurred in blood samples containing each of the antimalarial drugs used in the study is 





Serum sodium and potassium levels in the stored blood samples 
  
Sample The first day 24 Hrs Storage 48 Hrs Storage 
Na K Na K Na K 
C1 140.70 2.833 160.10 4.4 157.8 5.267 
C2 140.70 2.833 163.20 4.067 158. 5 5.633 
C3 140.70 2.833 166.70 4.2 162.9 5.233 
Ctrl 140.70 2.833 157.90 3.7 154.30 4.4 
Key:     C1= 250 µg/l chloroquine      C2= 500 µg/l chloroquine     C3= 1000 µg/l chloroquine   
Ctro= control .  Na: Sodium . K: Potassium    
                
Table 8 shows no evident increase in serum 
sodium level when blood samples contain the 
higher dose but an increase was seen with the 
increase in the time of storage.    
No statistical difference was detected between 
the results of the control and blood samples 
processed with 250µg/l chloroquine after 24  
and 48 hours of storage nor between samples 
containing 500µg/l and 1000µg/l chloroquine  
and the control after 48 hours of storage. 
Serum potassium levels were increased when 
the dose of chloroquine was high as well as 
when the time of storage was prolonged.  
After 48 hours no association was found 
between the results of the control and all 
blood samples. However, the upper levels of 
both serum potassium and sodium are within 
the normal range of the stored blood.    
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Discussion  
Although polymerase chain reaction (PCR) 
has an increased sensitivity over blood film 
examination, up to14000 parasites might be 
present in a full unit of blood (450 ml) and 
still pass undetected8. This justifies the failure 
of the screening system, employed by U.S.A 
blood banks to prevent the occurrence of such 
cases11.  
Treatment of all transfused patients or 
prospective donors is impractical and could 
precipitate adverse effects. Therefore, 
previous studies tried to find a feasible and 
safe method for eradication of transfusion-
induced malaria by in vitro processing of 
donors’ blood with different anti-malarial 
drugs to provide options, since sensitivity 
(effectiveness of the drug to kill the parasite) 
is fluctuated and a certain drug may be 
harmful to some patients. Ali and Kadaru 
have tested Fansidar12 and Quinine13 for in 
vitro eradication of transfusion-induced 
malaria. The present study used chloroquine 
because it is a safe and cheap anti-malarial 
drug.  
In the present study, the parasite numbers 
counted in samples loaded with chloroquine 
concentrations were significantly different 
from control samples. However, the 
determined optimal dose required for, the 
eradication of transfusion malaria, killing 
99% of the parasites was 626.1µg/l. This dose 
is more than that reported by Bruce Chwatt in 
198614 (250µg/l). This increase may be 
explained by resistance developed by the 
parasite towards the drug during the previous  
years and to the difference in the strains.   
The mean of the prothrombin time was 
increased in samples loaded with the higher 
concentration of chloroquine, which indicates 
the effects of this dose on plasma coagulation 
factors of the extrinsic system. However, it 
appears that the lethal dose does not 
significantly affect the plasma coagulation 
factors of the intrinsic system since the 
percentage of the increase is acceptable.   
The mean of the activated partial 
thromboplastin time correlated highly with 
the concentration of the applied drug 
increasing as the dose increased.  Also, the  
 
storage duration affects the values of the 
APTT in samples with drugs as well as 
control samples (without drug). This can be 
explained by the presence of the labile 
coagulation factor VIII, which has a half-life 
of 24 hours. This increase of APTT is 
acceptable even when the blood was stored 
for 48 hours.  
The means of the osmotic fragility values 
were correlated significantly with the storage 
time; which was increased when blood 
samples were stored for 48 hours compared to 
24 hours. The increase of the osmotic fragility 
values above the control is of no significance.   
Although some authors have described a 
relative increase in the haematocrit values of 
stored blood15, these values were decreased in 
the present study proportional to the storage 
period. Nevertheless, these values were not 
affected by adding chloroquine; the red blood 
cells which had haemolysed during storage 
may explain the decrease of packed cell 
volume (PCV) in the present study. 
The result of the total white blood cell count 
demonstrated no statistical difference, which 
indicates that the drugs used have no harmful 
effect on the viability of leucocytes.  
Also, the present study revealed a significant 
decrease in the number of platelets, which 
correlated with the increase in drug 
concentration. However, the effect of the 
lethal doses on platelets appears to be 
acceptable. Throughout the storage, the 
platelet counts are within the reference values 
of the stored blood. These findings are in 
agreement with those reported by Brien 
J.O.R.16 who stated that the dose of 0.1mmol/l 
chloroquine is too low to affect systemic 
platelets.  
The lysis percentage in the present study was 
increased relative to the concentrations of the 
applied drug as well as the storage period. 
Although the highest percentage of lysis was 
observed in samples processed with 500 and 
1000µg/l, it is low (0.7%) compared to that 
reported by Mollison (1%)15.  
Therefore, regardless of the mechanism by 
which haemolysis occurs, the survival of 
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processed blood stored at 4°C is within the 
normal range.  
Storage of donors’ blood in a blood bank 
refrigerator resulted in the increase of both 
sodium and potassium levels in all blood 
samples including the control, which is likely 
to be due to the halting of the active transport 
of these electrolytes across the red cell 
membrane at 2-8ºC. However, this is 
reversible after blood is transfused15. 
  The lethal doses of the applied drug used in 
this study appear to be safe for all constituents 
of the stored blood. Chloroquine was 
effective and the lethal dose (626.1µg/l) can 
kill 99% of the parasite within 24 hours. Its 
application to stored blood did not produce 
harmful effects on the various components of 
the blood. Moreover, the doses did not react 
with the constituents of the blood bag solution 
(anticoagulant  and preservatives) when 
added before blood collection. Also this 
procedure is inexpensive; one ampoule of 
chloroquine is adequate for 800 blood bags. 
Therefore, in vitro processing of donors’ 
blood with chloroquine appears to be 




In vitro processing of donors’ blood with 
chloroquine is a safe procedure for 
eradication of transfusion-induced malaria.  
Chloroquine demonstrated suitable sensitivity 
against malaria parasites and insignificant 
effect on the components of the stored blood 
compared to the infected-control samples 
without chloroquine. 
Future studies are recommended to select the 
most effective and safe antimalarial drug 
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